noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

United States Attorney's Office[...]

Miami Mother and Son Face Federal Fraud and Identity Theft Charges[...]
Abbott Laboratories

Notice of Proposed Sale of Securities (Form 144)
Apple Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Healthcare

Veradermics Inc.

04/27/2026 | Press release | Distributed by Public on 04/27/2026 15:17

Business/Financial Results (Form 8-K)

Item 2.02 Results of Operations and Financial Condition.

Veradermics, Incorporated (the "Company") reports that it had a preliminary unaudited amount of cash, cash equivalents and marketable securities of approximately $390.8 million as of March 31, 2026. This amount is preliminary and unaudited and is subject to completion of the Company's financial closing procedures. As a result, this amount may differ materially from the amount that will be reflected in the Company's unaudited condensed consolidated financial statements for the three months ended March 31, 2026. This preliminary unaudited financial data has been prepared by, and is the responsibility of, the Company's management. Deloitte & Touche LLP, the Company's auditor, has not audited, reviewed, examined, compiled, nor applied agreed-upon procedures with respect to the preliminary financial data. Accordingly, Deloitte & Touche LLP does not express an opinion or any other form of assurance with respect thereto.

Veradermics Inc. published this content on April 27, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 27, 2026 at 21:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]